Erschienen in:
12.02.2020 | Letter to the Editor
The use of deep neuromuscular blockade and reversal in ventral hernia surgery
Erschienen in:
Hernia
|
Ausgabe 2/2021
Einloggen, um Zugang zu erhalten
Excerpt
The use of deep neuromuscular blockade (NMB) (defined as train-of-four (TOF) count 0 and post-tetanic count (PTC) < 5) may improve surgical conditions during ventral hernia surgery, yet anaesthetists may have reluctance towards its use. Traditionally it has been associated with longer reversal times and incomplete recovery of NMB, which can lead to respiratory complications. However, the introduction of novel neuromuscular blockade reversal agents (e.g. sugammadex) has enabled rapid and effective reversal in patients with deep NMB, when compared to neostigmine, but this comes at a cost financially. …